Risk of microsatellite-unstable colorectal cancer is associated jointly with smoking and nonsteroidal anti-inflammatory drug use.

Smoking has been consistently associated with an increased risk of colorectal adenomas and hyperplastic polyps as well as colorectal cancer. Conversely, nonsteroidal anti-inflammatory drugs (NSAID) have been associated with reduced colorectal cancer risk. We conducted a population-based case-control study to evaluate the joint association between smoking and regular NSAID use with colorectal cancer risk; we also examined these associations stratified by tumor microsatellite instability (MSI). We analyzed 1,792 incident colorectal cancer cases and 1,501 population controls in the Seattle, Washington area from 1998-2002. MSI, defined as MSI high (MSI-H) or MSI-low/microsatellite stable (MSI-L/MSS), was assessed in tumors of 1,202 cases. Compared with nonsmokers, colorectal cancer risk was modestly increased among individuals who had ever smoked. Current NSAID use was associated with a 30% lower risk compared with nonusers. There was a statistically significant interaction between smoking duration and use of NSAIDs (P(interaction) = 0.05): relative to current NSAID users who never smoked, individuals who had both smoked for >40 years and had never used NSAIDs were at the highest risk for colorectal cancer (adjusted odds ratio, 2.8; 95% confidence intervals, 1.8-4.1). Compared with nonsmokers, there was a stronger association within MSI-H tumors with current smoking than there was within MSI-L/MSS tumors. Smokers of long duration were at elevated risk of MSI-H tumors even with NSAID use. The risk of MSI-L/MSS tumors was not elevated among long-duration smokers with long exposure to NSAIDs but was elevated among long-duration smokers who had never used NSAIDs. There seems to be a synergistic inverse association (implying protection) against colorectal cancer overall as a result of NSAID use and nonsmoking, but risk of MSI-H colorectal cancer remains elevated among smokers even when they have a history of NSAID use.

[1]  R. Ward,et al.  Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. , 2001, Journal of the National Cancer Institute.

[2]  D. Shibata,et al.  Dietary heterocyclic amines and microsatellite instability in colon adenocarcinomas. , 2001, Carcinogenesis.

[3]  S. Shapiro,et al.  NSAIDs and risk of colorectal cancer according to presence or absence of family history of the disease , 2000, Cancer Causes & Control.

[4]  J. Potter,et al.  Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer. , 2001, Cancer research.

[5]  E. Friedberg.  How nucleotide excision repair protects against cancer , 2001, Nature Reviews Cancer.

[6]  N. Breslow,et al.  The analysis of case-control studies , 1980 .

[7]  P. Newcomb,et al.  Cigarette smoking in relation to risk of large bowel cancer in women. , 1995, Cancer research.

[8]  P. Knekt,et al.  Smoking and risk of colorectal cancer. , 1998, British Journal of Cancer.

[9]  H. Rubin.  Synergistic mechanisms in carcinogenesis by polycyclic aromatic hydrocarbons and by tobacco smoke: a bio-historical perspective with updates. , 2001, Carcinogenesis.

[10]  B. Rump,et al.  Long-Term Use of Nonsteroidal Antiinflammatory Drugs and the Risk of Colorectal Adenomas , 2000, Digestion.

[11]  M. Leppert,et al.  Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. , 2000, Journal of the National Cancer Institute.

[12]  E. Rimm,et al.  Aspirin Use and the Risk for Colorectal Cancer and Adenoma in Male Health Professionals , 1994, Annals of Internal Medicine.

[13]  P. Newcomb,et al.  The health consequences of smoking. Cancer. , 1992, The Medical clinics of North America.

[14]  A. Wolk,et al.  Long‐term tobacco smoking and colorectal cancer in a prospective cohort study , 2001, International journal of cancer.

[15]  J. Hanley,et al.  Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing , 1999, British Journal of Cancer.

[16]  W. Ray,et al.  Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer: a population-based study. , 1999, Archives of internal medicine.

[17]  D. Kromhout,et al.  Meat consumption, cigarette smoking, and genetic susceptibility in the etiology of colorectal cancer: results from a Dutch prospective study , 2002, Cancer Causes & Control.

[18]  E. Giovannucci.  An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[19]  Daniel J Sargent,et al.  Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  P. Simpson,et al.  Statistical methods in cancer research , 2001, Journal of surgical oncology.

[21]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[22]  L. G. García Rodríguez,et al.  Reduced incidence of colorectal adenoma among long-term users of nonsteroidal antiinflammatory drugs: a pooled analysis of published studies and a new population-based study. , 2000, Epidemiology.

[23]  P. Patrignani,et al.  Nonsteroidal anti-inflammatory drugs, COX-2 and colorectal cancer. , 2000, Toxicology letters.

[24]  J. Baron,et al.  Reduced risk of large-bowel adenomas among aspirin users. The Polyp Prevention Study Group. , 1993, Journal of the National Cancer Institute.

[25]  E. Giovannucci,et al.  Tobacco, colorectal cancer, and adenomas: a review of the evidence. , 1996, Journal of the National Cancer Institute.

[26]  B. Levin,et al.  Aspirin and other nonsteroidal anti-inflammatory drugs and risk of colorectal adenomatous polyps among endoscoped individuals. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[27]  G. Beck,et al.  A randomized trial of aspirin to prevent colorectal adenomas. , 2003, The New England journal of medicine.

[28]  Hua Zhao,et al.  Genetic susceptibility to tobacco-related cancer , 2004, Oncogene.

[29]  D. R. Duckett,et al.  Recognition and repair of compound DNA lesions (base damage and mismatch) by human mismatch repair and excision repair systems , 1997, Molecular and cellular biology.

[30]  Office on Smoking.  The Health Consequences of Smoking , 2004 .

[31]  J. Potter,et al.  CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk. , 2001, Cancer research.

[32]  Michael J Thun,et al.  Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. , 2002, Journal of the National Cancer Institute.

[33]  M. Thun,et al.  Cigarette smoking and colorectal cancer mortality in the cancer prevention study II. , 2000, Journal of the National Cancer Institute.

[34]  J. Potter,et al.  Tobacco use and colon cancer , 1997, International journal of cancer.

[35]  A. Miller,et al.  Prospective cohort study of cigarette smoking and colorectal cancer risk in women , 2002, International journal of cancer.

[36]  T. Lesnick,et al.  Higher risk of mismatch repair-deficient colorectal cancer in alpha(1)-antitrypsin deficiency carriers and cigarette smokers. , 2000, Molecular genetics and metabolism.

[37]  M. Schuler.  Aspirin and the risk of colorectal cancer in women. , 1996, The New England journal of medicine.

[38]  S N Thibodeau,et al.  Microsatellite instability in cancer of the proximal colon. , 1993, Science.

[39]  E. Giovannucci.  The prevention of colorectal cancer by aspirin use. , 1999, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[40]  W. Willett,et al.  A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. women. , 1994, Journal of the National Cancer Institute.

[41]  N. Breslow,et al.  Statistical methods in cancer research: volume 1- The analysis of case-control studies , 1980 .

[42]  M. Thun,et al.  Aspirin use and reduced risk of fatal colon cancer. , 1991, The New England journal of medicine.

[43]  B. Leggett,et al.  Hyperplastic polyps and DNA microsatellite unstable cancers of the colorectum , 2000, Histopathology.

[44]  K. Anderson,et al.  Dietary intake and microsatellite instability in colon tumors , 2001, International journal of cancer.

[45]  R. Glynn,et al.  Lifetime cigarette smoking and colorectal cancer incidence in the Physicians' Health Study I. , 2000, Journal of the National Cancer Institute.

[46]  P. Remington,et al.  Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[47]  E. Rimm,et al.  A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. men. , 1994, Journal of the National Cancer Institute.

[48]  S. Wacholder,et al.  Risk factors for colorectal cancer in a prospective study among U.S. white men , 1998, International journal of cancer.

[49]  John D Potter,et al.  Risk factors for hyperplastic and adenomatous polyps: evidence for malignant potential? , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[50]  A. Neugut,et al.  Cigarette smoking and other behavioral risk factors for recurrence of colorectal adenomatous polyps (New York City, NY, USA) , 1994, Cancer Causes & Control.

[51]  S Srivastava,et al.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.

[52]  P. Trott,et al.  International Classification of Diseases for Oncology , 1977 .

[53]  Susan Halabi,et al.  A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. , 2003, The New England journal of medicine.

[54]  F. Gilliland,et al.  Patient and tumor characteristics of colon cancers with microsatellite instability: a population-based study. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[55]  S. Shapiro,et al.  A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. , 1991, Journal of the National Cancer Institute.

[56]  J. Mclaughlin,et al.  Increased risk of colorectal cancer among smokers: Results of a 26‐year follow‐up of us veterans and a review , 1994, International journal of cancer.

[57]  H. Kashihara,et al.  Case-control study of colorectal carcinoma in situ and cancer in relation to cigarette smoking and alcohol use (Japan) , 1997, Cancer Causes & Control.

[58]  B. Rump,et al.  Long-term use of nonsteroidal antiinflammatory drugs and the risk of colorectal adenomas. The Colorectal Adenoma Study Group. , 2000, Digestion.